The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Open accessAbstract
The cellular hallmarks of Parkinson's disease (PD) are the loss of nigral dopaminergic neurons and the formation of α-synuclein-enriched Lewy bodies and Lewy neurites in the remaining neurons. Based on the topographic distribution of Lewy bodies established after autopsy of brains from PD patients, Braak and coworkers hypothesized that Lewy pathology primes in the enteric nervous system and spreads to the brain, suggesting an active retrograde transport of α-synuclein (the key protein component in Lewy bodies), via the vagal nerve. This hypothesis, however, has not been tested experimentally thus far. Here, we use a human PD brain lysate containing different forms of α-synuclein (monomeric, oligomeric and fibrillar), and recombinant α-synuclein in an in vivo animal model to test this hypothesis. We demonstrate that α-synuclein present in the human PD brain lysate and distinct recombinant α-synuclein forms are transported via the vagal nerve and reach the dorsal motor nucleus of the vagus in the brainstem in a time-dependent manner after injection into the intestinal wall. Using live cell imaging in a differentiated neuroblastoma cell line, we determine that both slow and fast components of axonal transport are involved in the transport of aggregated α-synuclein. In conclusion, we here provide the first experimental evidence that different α-synuclein forms can propagate from the gut to the brain, and that microtubule-associated transport is involved in the translocation of aggregated α-synuclein in neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, cellular and animal studies have provided a model for prion-like spread of α-synuclein from the gut to the brain via the enteric nervous system, chiefly through the vagus nerve [15–17].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [17]
In the citing paper
“Involvement of the vagal nerve in the propagation of α-synuclein from the gut to the brain was demonstrated by Holmqvist et al. [399].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [399]
In the citing paper
“In accordance with this hypothesis it has been shown that alphasynuclein can be retrogradely transported from the intestinal wall to the brain in rats (Holmqvist et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Holmqvist et al., 2014
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E. L., & Webb, W. W. (1976) · Biophysical Journal · doi:10.1016/s0006-3495(76)85755-4 · Cited by 2,717
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citationLewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
Cited by
Sorted by citations
Items 501–600 of 925
Defining Dysbiosis in Disorders of Movement and Motivation
Fields, C. T., Sampson, T. R., Bruce‐Keller, A. J., Kiraly, D. D., Hsiao, E. Y., & Vries, G. J. D. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1672-18.2018 · Cited by 18
Neuro-Immune Networks in Gastrointestinal Disorders
Khalil, M., Zhang, Z., & Engel, M. A. (2019) · Visceral Medicine · doi:10.1159/000496838 · Cited by 18
Metabolomic analysis of serum using proton NMR in 6-OHDA experimental PD model and patients with PD.
Kumari, S., Kumaran, S., Goyal, V., Bose, S., Jain, S., Dwivedi, S., Srivastava, A., & Jagannathan, N. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104670 · Cited by 17
Chiu, W., Kovacheva, L., Musgrove, R. E., Arien‐Zakay, H., Koprich, J. B., Brotchie, J. M., Yaka, R., Ben‐Zvi, D., Hanani, M., Roeper, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd3994 · Cited by 20
Ternák, G., Németh, M., Rozanovic, M., Márovics, G., & Bogár, L. (2022) · Antibiotics · doi:10.3390/antibiotics11091145 · Cited by 18
Grathwohl, S., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Duran-Pacheco, G., Siebourg-Polster, J., Oroszlan-Szovik, K., Remy, H., et al. (2020) · doi:10.21203/rs.3.rs-100199/v1 · Cited by 17
Tiwari, R. K., Moin, A., Rizvi, S. M. D., Shahid, S. M. A., & Bajpai, P. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00696-6 · Cited by 19
Miranda-Ribera, A., Serena, G., Liu, J., Fasano, A., Kingsbury, M. A., & Fiorentino, M. R. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.2000299 · Cited by 18
Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
Basellini, M. J., Kothuis, J. M., Comincini, A., Pezzoli, G., Cappelletti, G., & Mazzetti, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802033 · Cited by 17
Sharrad, D. F., Chen, B. N., Gai, W., Vaikath, N. N., El‐Agnaf, O. M. A., & Brookes, S. J. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12985 · Cited by 16
Does Parkinson's disease start in the gut?
Gershanik, O. S. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170188 · Cited by 19
Modulation of Innate Immunity by Amyloidogenic Peptides
Westwell-Roper, C. Y., & Verchere, C. B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.005 · Cited by 17
Kang, X., Ploner, A., Ludvigsson, J. F., Williams, D. M., Larsson, H., Pedersen, N. L., & Wirdefeldt, K. (2020) · European Journal of Neurology · doi:10.1111/ene.14400 · Cited by 17
Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches
Colombo, D., Pnevmatikou, P., Melloni, E., & Keywood, C. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1800454 · Cited by 18
Gastrointestinal dysfunction in the synucleinopathies
Chung, K. A., & Pfeiffer, R. F. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00745-7 · Cited by 17
Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population
Kang, X., Ploner, A., Roelstraete, B., Khalili, H., Williams, D. M., Pedersen, N. L., Ludvigsson, J. F., & Wirdefeldt, K. (2021) · Movement Disorders · doi:10.1002/mds.28594 · Cited by 17
The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy
Kakoty, V., Sarathlal, K. C., Dubey, S. K., Yang, C. H., Kesharwani, P., & Taliyan, R. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135865 · Cited by 18
Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?
Zhang, J., Tang, Q., & Zhu, L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/1391384 · Cited by 17
Ma, X., Wang, Q., Yuan, W., Wang, Y., Zhou, F., Kang, K., Tong, X., & Liu, Z. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab046 · Cited by 17
Distribution of α-Synuclein Aggregation in the Peripheral Tissues
Li, Y., Zhou, T.-T., Zhang, Y., Chen, N., & Yuan, Y. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03586-0 · Cited by 18
Bai, X., Luo, Y., Fan, W., Zhang, Y.-M., & Liao, X. (2022) · Plant Foods for Human Nutrition · doi:10.1007/s11130-022-01016-8 · Cited by 17
Liu, Y., Liu, X., Ye, Q., Wang, Y., Zhang, J., Lin, S., Wang, G., Yang, X., Zhang, J., Chen, S., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06429 · Cited by 16
Zheng, H., Shi, C., Luo, H., Fan, L., Yang, Z., Hu, X., Zhang, Z., Zhang, S., Hu, Z., Fan, Y., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420943180 · Cited by 21
Chen, W., Bi, Z., Zhu, Q., Gao, H., Fan, Y., Zhang, C., Liu, X., & Ye, M. (2021) · PubMed Central · Cited by 16
Arabia, G., Martino, A., & Moro, E. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.06.010 · Cited by 16
Raj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 16
Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders
Yu, L.-E., & Li, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10102577 · Cited by 16
CAVALCANTI, S. A. D. Q., de Almeida, L. A., & Gasparotto, J. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578171 · Cited by 16
Li, Y., Tong, Q., Wang, Y., Cheng, Y., Geng, Y., Tian, T., Yuan, Y., Fan, Y., Lu, M., & Zhang, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01824-8 · Cited by 17
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Vilela, C., Araújo, B., Soares-Guedes, C., Caridade-Silva, R., Martins‐Macedo, J., Teixeira, C., Gomes, E. D., Prudêncio, C., Vieira, M., & Teixeira, F. G. (2024) · Cells · doi:10.3390/cells13090770 · Cited by 18
Alam, K., Nair, L. S., Mukherjee, S., Kaur, K., Singh, M., Kaity, S., Ravichandiran, V., Banerjee, S., & Roy, S. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-024-00282-6 · Cited by 16
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo
Braczynski, A. K., Sevenich, M. M., Gering, I., Kupreichyk, T., Agerschou, E. D., Kronimus, Y., Habib, P., Stoldt, M., Willbold, D., Schulz, J. B., et al. (2022) · Biomolecules · doi:10.3390/biom12030469 · Cited by 17
Prion-like propagation of α-synuclein in the gut-brain axis
Chen, Y., Shao, Q.-H., Yuan, Y., & Chen, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.002 · Cited by 15
Muronetz, V. I., Kudryavtseva, S. S., Leisi, E. V., Kurochkina, L. P., Barinova, K. V., & Schmalhausen, E. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052747 · Cited by 15
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators
Schmitt, V., Masanetz, R. K., Weidenfeller, M., Ebbinghaus, L. S., Süß, P., Rosshart, S. P., von Hörsten, S., Zunke, F., Winkler, J., & Xiang, W. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114574 · Cited by 16
The role of the gut microbiota in neurodegenerative diseases targeting metabolism
Fu, Y., Gu, Z., Cao, H., Zuo, C., Huang, Y., Song, Y., Jiang, Y., & Wang, F. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1432659 · Cited by 17
Kumar, R., Kumari, R., Kumar, S., Jangir, D. K., & Maiti, T. K. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.7b01727 · Cited by 15
Liu, J. Y. H., Sun, M. Y. Y., Sommerville, N. R., Ngan, M. P., Ponomarev, E. D., Lin, G., & Rudd, J. A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111396 · Cited by 15
Valderhaug, V. D., Heiney, K., Ramstad, O. H., Bråthen, G., Kuan, W., Nichele, S., Sandvig, A., & Sandvig, I. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00413.2020 · Cited by 13
Nicastro, L. K., de Anda, J., Jain, N., Grando, K. C. M., Miller, A. L., Bessho, S., Gallucci, S., Wong, G. C. L., & Tükel, Ç. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010742 · Cited by 18
Takahashi, R., Yamakado, H., Uemura, N., Taguchi, T., & Ueda, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093994 · Cited by 19
Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis
Walker, A. C., Bhargava, R., Dove, A. S., Brust, A. S., Owji, A. A., & Czyż, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094807 · Cited by 15
Clinical progression and genetic pathways in body-first and brain-first Parkinson’s disease
Passaretti, M., Veréb, D., Mijalkov, M., Chang, Y.-W., Zhao, H., Gerbolés, B. Z., Sun, J., Volpe, G., Rivera, N. V., Bologna, M., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00866-5 · Cited by 22
Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model
Lamontagne‐Proulx, J., Coulombe, K., Dahhani, F., Côté, M., Guyaz, C., Tremblay, C., Marzo, V. D., Flamand, N., Calon, F., & Soulet, D. (2021) · Nutrients · doi:10.3390/nu13124218 · Cited by 14
Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
Balan, Y., Archana Gaur, T., Sakthivadivel, V., Kamble, B. D., & Sundaramurthy, R. (2021) · Cureus · doi:10.7759/cureus.19740 · Cited by 14
Mitochondria-Microbiota Interaction in Neurodegeneration
Krämer, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.776936 · Cited by 14
Heng, Y., Li, Y., Wen, L., Yan, J., Chen, N., & Yuan, Y. (2022) · Molecules · doi:10.3390/molecules27217414 · Cited by 15
Balsamo, J. M., Zhou, K., Kammarchedu, V., Ebrahimi, A., & Bess, E. N. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00106 · Cited by 13
Feng, M., Zou, Z., Shou, P., Peng, W., Liu, M., & Li, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1479343 · Cited by 14
Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
Rajput, C., Sarkar, A., Sachan, N., Rawat, N., & Singh, M. P. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03187-9 · Cited by 13
Bibliometric Visualization Analysis of Microbiome-Gut-Brain Axis from 2004 to 2020
Wang, H., Long, T., You, J., Li, P., & Xu, Q. (2022) · Medical Science Monitor · doi:10.12659/msm.936037 · Cited by 13
Krasko, M. N., Szot, J. C., Lungova, K., Rowe, L. M., LEVERSON, G. E., Kelm‐Nelson, C. A., & Ciucci, M. R. (2023) · Dysphagia · doi:10.1007/s00455-023-10567-0 · Cited by 13
Progesterone: A Neuroprotective Steroid of the Intestine
Stegemann, L. N., Neufeld, P. M., Hecking, I., Vorgerd, M., Matschke, V., Stahlke, S., & Theiß, C. (2023) · Cells · doi:10.3390/cells12081206 · Cited by 12
Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
Mazzotta, G. M., Ceccato, N., & Conte, C. (2023) · Cells · doi:10.3390/cells12091231 · Cited by 13
Maturation, Morphology, and Function: The Decisive Role of Intestinal Flora on Microglia: A Review
Liu, L., Tong, F., Li, H., Bin, Y., Ding, P., Peng, L., Liu, Z., & Dong, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203070 · Cited by 14
Intestinal Barrier Function and Neurodegenerative Disease
Wu, S., Yang, L., Fu, Y., Liao, Z., Cai, D., & Liu, Z. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273264097231116103948 · Cited by 13
Andersen, K. K., Vad, B. S., Kjær, L., Tolker‐Nielsen, T., Christiansen, G., & Otzen, D. E. (2018) · FEBS Letters · doi:10.1002/1873-3468.13038 · Cited by 13
α-Synuclein 2.0 — Moving towards Cell Type Specific Pathophysiology
Thakur, P. S., Chiu, W., Roeper, J., & Goldberg, J. A. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.005 · Cited by 13
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
Sim, H., Lee, J., Yoo, H. M., Cho, S., Lee, H., Baek, A., Kim, J., Seo, H., Kweon, M., Kim, H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103455 · Cited by 12
Managing the Microbiome: How the Gut Influences Development and Disease
Weinstein, N., Garten, B., Vainer, J., Minaya, D. M., & Czaja, K. (2020) · Nutrients · doi:10.3390/nu13010074 · Cited by 14
Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
Li, T., Qiu, T., Jiang, F., Cai, H., & Le, W. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00531-3 · Cited by 15
Chaturvedi, M., Raj, R., Yadav, S. K., Srivastava, T., Devi, S., Dharmadana, D., Valéry, C., Sharma, S., Kumar, D., & Priya, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00234 · Cited by 13
Brain–Periphery Axes: The Potential Role of Extracellular Vesicles-Delivered miRNAs
D’Amico, G., Carista, A., Manna, O. M., Paladino, L., Picone, D., Sarullo, S., Sausa, M., Cappello, F., Vitale, A. M., & Bavisotto, C. C. (2024) · Biology · doi:10.3390/biology13121056 · Cited by 13
Lewy body diseases and the gut
Sampson, T. R., Tansey, M. G., West, A. B., & Liddle, R. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00804-5 · Cited by 13
Ohira, J., Sawamura, M., Kawano, K., Sato, R., Taguchi, T., Ishimoto, T., Ueda, J., Ikuno, M., Matsuzawa, S., Matsuzaki, K., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01080-2 · Cited by 15
Ensemencement et propagation des lésions dans les maladies neurodégénératives: un nouveau paradigme
Duyckaerts, C. J., Seilhean, D., Sazdovitch, V., Plu, I., Delatour, B., & Potier, M. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30883-0 · Cited by 12
Christensen, L. F. B., Alijanvand, S. H., Burdukiewicz, M., Herbst, F., Kjeldal, H., Dueholm, M. S., & Otzen, D. E. (2021) · Protein Science · doi:10.1002/pro.4137 · Cited by 11
Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease
Olubodun-Obadun, T. G., Ishola, I. O., & Adeyemi, O. O. (2022) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0144 · Cited by 13
Wang, C., Su, T., Xiao, L., Wang, Y., Huo, X., Li, W., Ding, J., & Sun, T. S. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5366 · Cited by 12
Self-citationSpecial issue “Parkinson’s disease”
Braak, H., Tredici-Braak, K. D., & Gasser, T. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2863-5 · Cited by 12
Camacho, R., Täuber, D., Hansen, C., Shi, J., Bousset, L., Melki, R., Li, J., & Scheblykin, I. G. (2018) · Communications Biology · doi:10.1038/s42003-018-0156-x · Cited by 12
Self-citationGil-Martínez, A. L., Estrada, C. M., Cuenca‐Bermejo, L., Cano, J. A., Valiente, M., Martínez, C. M., Fernández‐Villalba, E., & Herrero, M. T. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0010-z · Cited by 13
Tang, C., Wang, W., Shi, M., Zhang, N., Zhou, X., Li, X., Ma, C., Chen, G., Xiang, J., & Gao, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00644 · Cited by 15
Pietraszko, W., Furgała, A., Gorecka-Mazur, A., Kwinta, B., Kaszuba-Zwoińska, J., Polak, J., Fiszer, U., Gil, K., & Krygowska-Wajs, A. (2020) · Peptides · doi:10.1016/j.peptides.2020.170299 · Cited by 7
“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
Ray, B., Mahalakshmi, A. M., Tuladhar, S., Bhat, A., Srinivasan, A., Pellegrino, C., Kannan, A., Bolla, S. R., Chidambaram, S. B., & Sakharkar, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673395 · Cited by 14
Zhang, X.-L., Zhang, X.-H., Xiao, Y., Zheng, L., Feng, X., Liu, C., Quan, Z., Zhang, Y., & Zhu, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.770841 · Cited by 12
The gut-brain axis in the pathogenesis of Parkinson’s disease
Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12
Milk exosomal microRNAs: friend or foe?—a narrative review
Melnik, B. C., Weiskirchen, R., & Schmitz, G. (2022) · ExRNA · doi:10.21037/exrna-22-5 · Cited by 13
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathologyPreprint
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/505164 · Cited by 13
The Gut–Brain Axis in Parkinson's DiseasePreprint
Gao, V., Crawford, C. V., & Burré, J. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041618 · Cited by 15
Zhang, Y., Wang, C., Wang, Y., & Wang, T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13301-y · Cited by 11
Inter-Organ Crosstalk in Neurodegenerative Disease
Carata, E., Destino, M., Tenuzzo, B. A., & Panzarini, E. (2025) · Life · doi:10.3390/life15101499 · Cited by 14
Raj, A., Kaushal, A., & Datta, I. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24994 · Cited by 11
Cui, H., Elford, J. D., Alitalo, O., Perez‐Pardo, P., Tampio, J., Huttunen, K. M., Kraneveld, A. D., Forsberg, M., Myöhänen, T. T., & Jalkanen, A. J. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.05.007 · Cited by 14
Zeolite and Neurodegenerative Diseases
Panaiotov, S., Tancheva, L. P., Kalfin, R. E., & Petkova-Kirova, P. S. (2024) · Molecules · doi:10.3390/molecules29112614 · Cited by 15
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Kishanchand, D. K., A., A. K. K., Chandrababu, K., Philips, C. A., Sivan, U., & Chakrapani, P. S. B. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70016 · Cited by 13
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14
Fang, X. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0239-x · Cited by 11
Dhapola, R., Kumari, S., Sharma, P., Paidlewar, M., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.01.001 · Cited by 10
PrP meets alpha‐synuclein: Molecular mechanisms and implications for disease
Vieira, T. C. R. G., Barros, C. A., Domingues, R., & Outeiro, T. F. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15992 · Cited by 10
Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans model
Ullah, I., Zhao, L., Shahab Uddin, M. S., Zhou, Y., Wang, X., & Li, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1358141 · Cited by 10
Shin, C., Kim, S., Park, S., Kim, J., Lee, J., Chung, S. J., Kim, J. W., Ahn, T., Park, K. W., Shin, J. H., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00766-3 · Cited by 10
Gorecki, A. M., Anyaegbu, C. C., Fitzgerald, M., Fuller, K. A., & Anderton, R. S. (2024) · Methods · doi:10.1016/j.ymeth.2024.10.009 · Cited by 11
Movement disorders: advances in 2015
Hattori, N. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00362-2 · Cited by 10
Keskin, I., Bidhendi, E. E., Marklund, M., Andersen, P. M., Brännström, T., Marklund, S. L., & Nordström, U. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01211-9 · Cited by 10
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson’s disease
Nord, M. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-136560 · Cited by 10
Fang, C., Tseng, C., Wu, S., Chen, W. T., & Muo, C. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4127-z · Cited by 10
Initiation and Transmission of α-Synuclein Pathology in Parkinson’s Disease
Mazurskyy, A., & Howitt, J. A. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02896-0 · Cited by 10
Sevgi, F., Brauchle, E., Berrio, D. A. C., Schenke‐Layland, K., Casadei, N., Salker, M. S., Rieß, O., & Singh, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.664365 · Cited by 10
Christmann, A., Gries, M., Scholz, P., Stahr, P. L., Law, J. K. Y., Schulte, S., Martin, M., Lilischkis, R., Ingebrandt, S., Keck, C. M., et al. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0259 · Cited by 11
Metadata
- Authors
- Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y.
- Affiliations
- Lund University (SE)
- Centre National de la Recherche Scientifique (FR)
- Northeastern University (CN)
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2014-10-09
- Volume
- 128
- Issue
- 6
- Pages
- 805-820
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1995281235
- Cited by
- 925
- References
- 51
- Citations by year
- 2026: 47 · 2025: 67 · 2024: 73 · 2023: 67 · 2022: 110 · 2021: 132 · 2020: 102 · 2019: 107 · 2018: 75 · 2017: 59 · 2016: 43 · 2015: 38 · 2014: 3
- FWCI
- 30.94
- Type
- journal article
- Language
- en
- Open access
- green
- lup.lub.lu.se
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche (ANR-11-BSV8-0021)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, alpha-synuclein, Lewy bodies, gut-brain axis, vagus nerve, retrograde transport, enteric nervous system, dorsal motor nucleus of the vagus, axonal transport, alpha-synuclein aggregation, rat model
- MeSH terms
- Animals, Axonal Transport, Brain, Disease Models, Animal, Humans, Parkinson Disease, Recombinant Proteins, Vagus Nerve, Rats, Sprague-Dawley, Disease Progression, Gastrointestinal Tract, Cell Line, Tumor, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
